Tag Archive | "Hospira"

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


The term ‘top pharma’ can relate to the top pharmaceutical companies or the top 10 or 50… Read the full story

Hospira

Tags: , ,


Hospira is a top pharmaceutical company based in Illinois, USA. Read the full story

M&A activity for Hospira: 2005 – 2013

Tags: ,


Hospira has announced 7 M&A deals since 2005, with the lead deals being the acquisition of Mayne Pharma in 2006 and Orchid Chemicals and Pharma in 2010. Read the full story

Hospira: Partnering activity 2005-2013

Tags: , ,


Hospira is a big pharma company with headquarters in the USA. The company is the leading provider of injectable drugs and infusion technologies. Read the full story

Hospira: King of the injectables

Tags: , ,


Chicago based Hospira is a specialist provider of generic injectables and infusion technologies in the healthcare industry. Read the full story

Hospira: Company Profile

Tags: ,


Hospira, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

Hospira an acquisition takeover target?

Tags: , , ,


Hospira acquisition would provide an acquirer with ready entry to generics pharma sector Read the full story

Hospira & Q Core Medica in pharma partnering pact

Tags: , , ,


Hospira and Q Core Medical  signed a pharma partnering distribution agreement for the Q Core Sapphire multi-therapy infusion system. Read the full story

Hospira in pharma partnering with Orchid to acquire its API manufacturing & R&D facilities

Tags: , , ,


Hospira, a big pharma company singed a definitive pharma partnering agreement to acquire an active pharmaceutical ingredient (API) manufacturing facility, together with an associated research and development (R&D) facility, from Orchid Chemicals & Pharmaceuticals for approximately $200 million.

Read the full story

Pharma news: Pfizer, Hospira likely shoppers for Indian injectables star Agila

Tags: , , , ,


A shortage of injectable drugs in the U.S. means India’s Strides Arcolab Ltd. (STR) could sell a division that makes generic cancer treatments and antibiotics for more than the entire company’s market value.

Read the full story

cabannerad300x150new4gif
p2078300x150bannercpjpg
bm-banner-300x150-2png
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new2gif
pharmavenue-datesjpg
bm-banner-300x150-2png